Brain and Spine Tumor Program

Dr. Fonkem

Neuro-oncologist Ekokobe Fonkem, MD, discusses the multidisciplinary approach he uses to treat patients.

The Scott & White Neuroscience Institute offers expert care for patients battling tumors of the brain and spine. In collaboration with the Scott & White Cancer Institute, the Brain and Spine Tumor Program provides advanced treatment for patients with brain tumors and neurologic complications of cancer. Through an interdisciplinary team — made up of neurologists, neurosurgeons, neuro-oncologists, radiation oncologists and surgical oncologists — patients receive a personalized treatment plan, advanced diagnostics and state-of-the-art technology to treat cancer.

In 2012, Scott & White welcomed Dr. Ekokobe Fonkem as the new director of the Scott & White Brain and Spine Tumor program. A neuro-oncologist, Dr. Fonkem is specially-trained in neurology and oncology and specializes in brain tumors and tumors of the central nervous system.

Most brain and spine tumor patients will be seen in the Glenda Tanner Vasicek Cancer Treatment Center on the Temple campus. There, you will meet with your team of physicians to determine the best treatment options for you, including medical and surgical options.

> Learn more about the brain and spine cancer program at Scott & White

New treatment for patients with brain tumors

Patients with recurrent brain tumors can now receive a new treatment option at Scott & White that has proven to be effective in shrinking recurrent glioblastomas in patients and also prolonging life for some patients.

Scott & White is one of a few centers across the country to offer NovoTTF for the treatment of recurrent glioblastoma multiforme (GBM), which is the most commonly diagnosed brain tumor. Dr. Ekokobe Fonkem is using the new FDA approved technology, which uses electrical Tumor Treating Fields (TTFields) to inhibit tumor growth.

TTF therapy is delivered using non-invasive, insulated transducer arrays that are placed directly on the scalp in the region of the tumor. TTF does not deliver electric current to the tissue but creates an artificial, alternative electric field within the tumor, which disrupts cancer cell division and can cause the cancer cells to die.

NovoTTF therapy was developed to provide physicians and patients with a fourth treatment option for cancer in addition to surgery, radiation therapy and chemotherapy. 

For more information about NovoTTF or the Brain and Spine Tumor Program, call 254-724-4179.


Print
Text Size
A
A
A

© 2014 Scott & White. All Rights Reserved.